Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Valley Wealth Managers Inc. grew its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 44.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange ...

Sixteen “safer” Ideal GASV emerged as buys for July. Top-ten tickers to buy were: CALM; FSK; MPLX; ET; YRD; ING; MO; VZ; NWBI ...

A small island near Venice once used as a plague pit is set to become a public park for the city's residents.  Part of ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

The European Parliament’s rapporteur on the EU’s proposed 2040 climate target, the Czech MEP Ondrej Knotek of the Patriots for Europe (PfE) group, is seeking to rally parliamentary support to reject ...

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school ...

Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity ...

My, how time flies. This week marks week number 1,700 for our Real Estate Matters column. We’ll do the math for you: We’ve ...

I have never been what you could call a lucky person. I think I’m average in the luck department, but if a sea gull flew over ...